Waterdrop Releases the 2020-21 ESG Report – Striving to Provide High-quality and Sustainable Protection to Billions of Families
BEIJING, Aug. 4, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently released its "2020-21 Environmental, Social and Governance Report" (the "ESG report" or the "report"). This is the first ESG report published since the public offering of Waterdrop....
CGBio Signing a North America Out-license Contract on “Novosis rhBMP-2,” a Bone Substitute with Orthofix, USA
Embarking on a successful journey of exporting its home-grown product technology to North America, the largest market for bone substitutes Enabling fast bone formation by applying bone morphogenetic protein (rhBMP-2) and next-generation synthetic carrier SEOUL, South Korea and LEWISVILLE, Texas, Aug. 4, 2022 /PRNewswire/ -- CGBio (CEO Hyun Seung Yu), a company specialized in bio-regenerative medicine, announced on...
TCEB and Phuket Welcome Enquiry Mission Members from World Expo’s Governing Body to Assess Phuket’s Candidacy for Expo 2028
BANGKOK, Aug. 4, 2022 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in partnership with Phuket City and Thailand's Ministry of Public Health, welcomed nine Enquiry Mission Members from Bureau International des Expositions (BIE), the governing body of World Expos, as guests of the Thai Government from 24-29 July 2022 on their inspection trip to Bangkok and Phuket to evaluate...
The Debut of TIANGEN Received Passionate Feedback at AACC 2022
CHICAGO , Aug. 4, 2022 /PRNewswire/ -- TIANGEN, a high-tech biological enterprise, demonstrated its groundbreaking nucleic acid extraction solution and customer-oriented OEM model at AACC 2022 from July 26 to 28. The show received passionate feedback from more than 100 distributors and scientists working in molecular biology relevant fields. The most eye-catching product on display at...
Fullerton Health Completes Merger Led By RRJ Capital; Stronger Balance Sheet and New Corporate Structure Will Propel Post-Pandemic Growth Opportunities
SINGAPORE, Aug. 4, 2022 /PRNewswire/ -- Fullerton Health Corporation Limited ("Fullerton Health" or the "Company") announced today that it has completed a merger led by RRJ Capital ("RRJ") involving an equity injection by the private equity firm and a senior loan totalling S$390 million. The merger delivers a stronger balance sheet and...
RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT FROM NANOMAB
Radiopharm will shortly initiate a PD-L1 Phase 1 therapeutic study in Australia in patients with NSCLC Radiopharm acquired from NanoMab, Ltd. worldwide rights to PD-L1 technology for therapeutic use, as well as to imaging rights in China MELBOURNE, Australia, Aug. 4, 2022 /PRNewswire/ -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"),...
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA
HANGZHOU, China and SHAOXING, China, Aug. 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the Investigational New Drug (IND) application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for COVID-19, has been accepted by China National Medical Products Administration (NMPA). ASC10 is an orally bioavailable double prodrug which has a...
HAVAS HEALTH & YOU PARTNERS WITH REPUBLICA HAVAS TO CREATE REPUBLICA HAVAS HEALTH
New Offering Architects Health and Wellness Programs that Lead Cultural Understanding, Foster Health Equity For Multicultural Populations and Bring Deep Fluency and Multicultural Capabilities to World's Largest Health Network NEW YORK, Aug. 3, 2022 /PRNewswire/ -- Havas Health & You, the world's largest health and wellness network, and industry leader Republica Havas...
Firmenich Appoints Maurizio Clementi ad interim President of its Taste & Beyond Division
GENEVA, Aug. 3, 2022 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, is pleased to announce the appointment of Maurizio Clementi as ad interim President of its Taste & Beyond division, effective immediately. This move follows former President Emmanuel Butstraen's recent appointment as Chief Integration Officer overseeing the upcoming...
ProfoundBio Receives FDA “Study May Proceed” Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer
SUZHOU, China and WOODINVILLE, Wash., Aug. 3, 2022 /PRNewswire/ -- ProfoundBio, an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its investigational new drug application (IND) to evaluate PRO1184 in patients with advanced cancer. PRO1184 is an antibody-drug conjugate comprising a folate receptor...
